TrialBMC ophthalmology2022

Effectiveness and safety of tafluprost in primary open-angle glaucoma and ocular hypertension: a post-marketing phase IV study in China.

Xinghuai Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.